LACunar Intervention (LACI-2) Trial-2

NCT03451591 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

363

Enrollment

OTHER

Sponsor class

Conditions

Cerebral Small Vessel Diseases
Stroke, Lacunar

Interventions

DRUG: Isosorbide Mononitrate XL (ISMN)
DRUG: Cilostazol
DRUG: ISMN XL and Cilostazol
OTHER: Neither ISMN nor cilostazol

Sponsor

University of Edinburgh

Collaborators

[object Object]
[object Object]